Hong Kong Stocks Surge | Sino Biopharmaceutical (01801.HK) Rises Over 3% as Oral Small Molecule GLP-1R Agonist IBI3032 IND Approved by U.S. FDA

According to the Zhitong Finance APP, Xinda Biology (01801.HK) rose more than 3%, as of the time of publication, it rose 3.12% to HK$95.8, with a trading volume of 2.19 billion Hong Kong dollars.